Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

21.82
+0.56002.63%
Post-market: 22.090.2685+1.23%19:41 EDT
Volume:1.42M
Turnover:31.26M
Market Cap:4.24B
PE:-43.57
High:22.37
Open:21.44
Low:21.38
Close:21.26
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:90.19M
Volume Ratio:0.58
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.45
PE(LYR):-13.47

Loading ...

Legend Biotech CFO Carlos E Santos Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Legend Biotech Director Corazon D. Sanders Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Legend Biotech CEO and Director Huang Ying files initial beneficial ownership statement

Reuters
·
Mar 19

Legend Biotech files Form 3 initial beneficial ownership statement for director Wang Ye

Reuters
·
Mar 19

GENSCRIPT BIO (01548) Surges Over 5% on Strong Annual Revenue Growth and Narrowed Losses at Legend Biotech

Stock News
·
Mar 17

Legend Biotech (LEGN) Is Up 7.3% After CARVYKTI Reaches Profitability And 10,000 Patients Treated

Simply Wall St.
·
Mar 13

Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says

MT Newswires Live
·
Mar 11

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
Mar 11

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Medtronic (MDT)

TIPRANKS
·
Mar 11

Legend Biotech price target lowered to $49 from $50 at Morgan Stanley

TIPRANKS
·
Mar 11

Legend Biotech price target lowered to $62 from $66 at RBC Capital

TIPRANKS
·
Mar 11

Morgan Stanley Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Mar 11

Legend Biotech (LEGN) Receives a Buy from Oppenheimer

TIPRANKS
·
Mar 11

RBC Capital Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Mar 11

Piper Sandler Remains a Buy on Legend Biotech (LEGN)

TIPRANKS
·
Mar 11

RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating

MT Newswires Live
·
Mar 11

Genscript Flags Legend Biotech’s 2025 Results, Cautions Investors on Risk

TIPRANKS
·
Mar 10

Legend Biotech Q4 revenue slightly misses; expects operating profit in 2026

Reuters
·
Mar 10

Earnings Flash (LEGN) Legend Biotech Posts Q4 Loss $0.08 a Share, vs. FactSet Est of $0.02 EPS

MT Newswires Live
·
Mar 10

Legend Biotech Q4 Adj. EPS $0.01 Beats $(0.11) Estimate, Sales $306.300M Miss $306.875M Estimate.

Benzinga Earnings
·
Mar 10